Company Filing History:
2 out of 9 
1 out of 1 
1 out of 3 Years Active: 1998-2005
Title: The Innovative Contributions of Hugh O. Pettit
Introduction: Hugh O. Pettit, an accomplished inventor based in Cary, NC, has made significant strides in the field of pharmaceuticals. With a portfolio of four patents, his work primarily focuses on enhancing the safety and efficacy of opioid medications.
Latest Patents: Among his latest innovations, Pettit has developed compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds. One of his notable inventions involves a method that reduces, treats, or prevents drug-mediated respiratory depression, muscle rigidity, or nausea/vomiting in an animal following the administration of a mixed delta/mu opioid agonist or a respiratory depression-mediating drug. This method includes administering an effective amount of a delta receptor agonist compound. Preferred examples of these compounds are diarylmethyl piperazine and diarylmethyl piperidine compounds, which prove beneficial in medical therapies aimed at alleviating respiratory depression associated with certain analgesics, particularly mu opiates.
Career Highlights: Hugh's career features significant contributions through his work with Delta Pharmaceuticals Ltd. and Delta Pharmaceutical, Inc. He has dedicated his professional life to advancing pharmaceutical research, especially in the realm of opioids, a critical area in providing safer pain management solutions.
Collaborations: Throughout his career, Hugh O. Pettit has collaborated with esteemed colleagues such as Kwen-Jen Chang and Robert W. McNutt, Jr. These partnerships have furthered research and development in opioid safety and efficacy.
Conclusion: Hugh O. Pettit stands out as a prominent figure in the field of pharmaceutical innovation. His work not only addresses critical issues associated with opioid medications but also sets a foundation for future advancements in pain management. As the healthcare industry continues to evolve, Pettit's contributions will undoubtedly have a lasting impact on the safety of opioid therapies.